Skip to Content
You are currently on the new version of our website. Access the old version .
MDPIMDPI
Sci. Pharm.Scientia Pharmaceutica
PDF
  • Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
  • Correction
  • Open Access

13 March 2014

Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]

,
,
,
and
1
Biotechnology High School of Sfax (ISBS),University of Sfax, Soukra Km 45; PO Box 261, Sfax 3038, Tunisia
2
Laboratory of Animal Ecophysiology, University of Sfax, Faculty of Sciences of Sfax, PO Box 95, Sfax 3052, Tunisia
3
Laboratory of Biochemistry and Enzymatic Engineering of Lipases, National School of Engineers of Sfax, University of Sfax, Sfax 3038, Tunisia
*
Author to whom correspondence should be addressed.
Sci. Pharm.2014, 82(2), 449-452;https://doi.org/10.3797/scipharm.1211-14corr
Version Notes
Order Reprints

Abstract

This is a corrigendum to the article 'Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats' [Sci Pharm. 2013; 81: 233–246]. Figure 6 is replaced.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Multiple requests from the same IP address are counted as one view.
Formulation and In Vitro Evaluation of Ofloxacin Tablets using Natural Gums as Binders
Previous
Selective Phosphodiesterase 4B Inhibitors: A Review
Next